Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Brockly

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
The Journal of Investigative Dermatology|September 21, 2000
Sustained systemic delivery of monoclonal antibodies by genetically modified skin fibroblastsD Noël, M Pelegrin, F Brockly, et al.
European Journal of Immunology|June 1, 1990
Definition of the human immunoglobulin variable lambda (IGLV) gene subgroupsP Chuchana, A Blancher, F Brockly, et al.
Nucleic Acids Research|May 25, 1989
First genomic sequence of a human Ig variable lambda gene belonging to subgroup I. Functional genes, pseudogenes and vestigial sequences are interspersed in the IGLV locusD Alexandre, P Chuchana, F Brockly, et al.
Nucleic Acids Research|February 11, 1989
SacI polymorphism defined by human T-cell receptor gamma (TCRG) variable gene V11N Ghanem, P Chuchana, P Dariavach, et al.
Human Gene Therapy|March 4, 2000
Antiviral activity of an intracellularly expressed single-chain antibody fragment directed against the murine leukemia virus capsid proteinM Marin, M Pelegrin-Zurilla, E Bachrach, et al.
British Journal of Haematology|December 1, 1989
No preferential use of the VH(V) family in human multiple myelomaG Clofent, F Brockly, T Commes, et al.
Nucleic Acids Research|May 25, 1989
First nucleotide sequence of a human immunoglobulin variable lambda gene belonging to subgroup IIF Brockly, D Alexandre, P Chuchana, et al.
Nucleic Acids Research|February 11, 1989
Two KpnI restriction fragment alleles of the human T-cell receptor delta (TRD) joining segment J2P Chuchana, Z Soua, N Ghanem, et al.
Oncogene|December 26, 2001
Identification of a C-terminal tripeptide motif involved in the control of rapid proteasomal degradation of c-Fos proto-oncoprotein during the G(0)-to-S phase transitionC Acquaviva, F Brockly, P Ferrara, et al.
Oncogene|April 21, 2001
Cellular and viral Fos proteins are degraded by different proteolytic systemsC Acquaviva, C Salvat, F Brockly, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
The Journal of Investigative Dermatology|September 21, 2000
Sustained systemic delivery of monoclonal antibodies by genetically modified skin fibroblastsD Noël, M Pelegrin, F Brockly, et al.
European Journal of Immunology|June 1, 1990
Definition of the human immunoglobulin variable lambda (IGLV) gene subgroupsP Chuchana, A Blancher, F Brockly, et al.
Nucleic Acids Research|May 25, 1989
First genomic sequence of a human Ig variable lambda gene belonging to subgroup I. Functional genes, pseudogenes and vestigial sequences are interspersed in the IGLV locusD Alexandre, P Chuchana, F Brockly, et al.
Nucleic Acids Research|February 11, 1989
SacI polymorphism defined by human T-cell receptor gamma (TCRG) variable gene V11N Ghanem, P Chuchana, P Dariavach, et al.
Human Gene Therapy|March 4, 2000
Antiviral activity of an intracellularly expressed single-chain antibody fragment directed against the murine leukemia virus capsid proteinM Marin, M Pelegrin-Zurilla, E Bachrach, et al.
British Journal of Haematology|December 1, 1989
No preferential use of the VH(V) family in human multiple myelomaG Clofent, F Brockly, T Commes, et al.
Nucleic Acids Research|May 25, 1989
First nucleotide sequence of a human immunoglobulin variable lambda gene belonging to subgroup IIF Brockly, D Alexandre, P Chuchana, et al.
Nucleic Acids Research|February 11, 1989
Two KpnI restriction fragment alleles of the human T-cell receptor delta (TRD) joining segment J2P Chuchana, Z Soua, N Ghanem, et al.
Oncogene|December 26, 2001
Identification of a C-terminal tripeptide motif involved in the control of rapid proteasomal degradation of c-Fos proto-oncoprotein during the G(0)-to-S phase transitionC Acquaviva, F Brockly, P Ferrara, et al.
Oncogene|April 21, 2001
Cellular and viral Fos proteins are degraded by different proteolytic systemsC Acquaviva, C Salvat, F Brockly, et al.
Pageof 2